ABSTRACT TOPICS

Track A: Special Populations Safety

  1. Newborn and pediatric patients
  2. Women's Medicine and Maternal Health
  3. Older Patients
  4. Oncology Patients
  5. Immunotherapy

Track ​B: Digital Transformation & AI in Pharmacovigilance

  1. AI Applications and responsible use
  2. Digital tools
  3. Education AI based

Track C: Risk management

  1. Risk Communication
  2. Benefit- risk Assessment
  3. Risk Minimisation Methods and Policies

Track D: Regulatory science and PV Systems

  1. Harmonization
  2. Reliance and Worksharing
  3. PV policies, transparency and governance
  4. Regulatory affairs    

Track E: Culture, Trust and Ethics

  1. Culture of Safety 
  2. Building Trust Among Stakeholders
  3. Ethics Dilemas (not AI related)

Track F: Evidence generation, Pharmacoepidemiology and Signal Management

  1. Real World Evidence and Big Data
  2. Pharmacoepidemiology
  3. Signal management

Track G: Medication Errors

  1. Medication Errors Risk Mitigation
  2. Coordinated Actions for Medication Errors Management
  3. Policies,  Regulation and Government Actions in Medication Errors
  4. Medication Error Case of Study

Track H: Medical Devices  

  1. Medical Devices Risk Mitigation
  2. Combined Drug-Medical Devices Safety
  3. Coordinated Actions for Medical Devices Safety
  4. Policies, Regulation and Government Actions in Medical Device Safety
  5. Medical Device Case of Study

Track I: Wider PV Horizons

  1. Advanced Therapy Medicinal Products
  2. Pharmacogenomics
  3. Herbal and Traditional Medicines
  4. Selfcare and Cosmetic Products Vigilance
  5. Eco Pharmacovigilance 
  6. Biological and Biosimilars
  7. Veterinary Products Safety    

Track J: Vaccines & Public Health

  1. Vaccine Safety
  2. Community Pharmacovigilance
  3. Hospital Pharmacovigilance
  4. Antimicrobial Resistance
  5. Other Problems/conditions in Public Health

Track K: Regional Advances in Pharmacovigilance

  1. ISoP Chapters Advances
  2. Local Experiences        

Track L: Patient Development

  1. Patient Engagement and Empowerment
  2. Advocacy
  3. Education for patients
  4. Other actions for patients        

Track M: Professional Development

  1. Education and Qualification in PV
  2. Training and Certification
  3. Students involvement

Track N: Miscellaneous

  1. Miscellaneous

 

August 2025 | Launch of the Event

15 February 2026 | Call for Abstracts

30 April 2026 | Extended Submission Deadline 

1 July 2026 | Decisions on Abstract Selection

1 July 2026 | End of Early Bird Registration

21 September 2026 | On-Site Registration